-
1
-
-
0008947293
-
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia
-
(1998)
New Engl J Med
, vol.338
, pp. 962-968
-
-
Hansen, J.A.1
Gooley, T.A.2
Martin, P.J.3
Appelbaum, F.4
Chauncey, T.R.5
Clift, R.A.6
Petersdorf, E.W.7
Radich, J.8
Sanders, J.E.9
Storb, R.F.10
Sullivan, K.M.11
Anasetti, C.12
-
2
-
-
0028170517
-
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia
-
And the German CML Study Group.
-
(1994)
Blood
, vol.84
, pp. 4064-4077
-
-
Hehlmann, R.1
Heimpel, H.2
Hasford, J.3
Kolb, H.J.4
Pralle, H.5
Hossfeld, D.K.6
Queisser, W.7
Loffler, H.8
Hochhaus, A.9
Heinze, B.10
Georgii, A.11
Bartram, C.R.12
Griesshammer, M.13
Bergmann, L.14
Essers, U.15
Falge, C.16
Queisser, U.17
Meyer18
Walther, F.19
Fett, W.20
Kleeberg, U.R.21
Kabisch, A.22
Nerl, C.23
Zimmermann, R.24
Meuret, G.25
Tichelli, A.26
Kanz, L.27
Tigges, F.J.28
Schmid, L.29
Brockhaus, W.30
Tobler, A.31
Reiter, A.32
Perker, M.33
Emmerich, B.34
Verpoort, K.35
Zankovich, R.36
von Wussow37
Carbonell, F.38
Ansari, H.39
more..
-
3
-
-
0032478962
-
A new prognostic score for the survival of patients with chronic myeloid leukemia treated with interferon alfa
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 850-858
-
-
Hasford, J.1
Pfirrmann, M.2
Hehlmann, R.3
Allan, N.C.4
Baccarani, M.5
Kluin-Nelemans, J.6
Alimena, G.7
Steegmann, J.L.8
Ansari, H.9
-
5
-
-
0008116477
-
-
Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: A report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
-
(1997)
Bone Marrow Transplant
, vol.20
, pp. 11-19
-
-
van Rhee, F.1
Szydlo, R.M.2
Hermans, J.3
Devergie, A.4
Frassoni, F.5
Arcese, W.6
de Witte, T.7
Kolb, H.J.8
Niederwieser, D.9
Jacobsen, N.10
Gahrton, G.11
Bandini, G.12
Carreras, E.13
Bacigalupo, A.14
Michallet, M.15
Ruutu, T.16
Reiffers, J.17
Goldman18
Gratwohl, A.19
Apperley, J.F.20
Labopin, M.21
Madrigal, A.22
Prentice, H.G.23
Jouet, J.P.24
Hertenstein, B.25
Evensen, S.A.26
Ljungman, P.27
Nagler, A.28
Clark, R.E.29
more..
-
6
-
-
6844259874
-
Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia
-
And the German CML Study Group.
-
(1998)
Blood
, vol.91
, pp. 1810-1819
-
-
Gale, R.P.1
Hehlmann, R.2
Zhang, M.-J.3
Hasford, J.4
Goldman, J.M.5
Heimpel, H.6
Hochhaus, A.7
Klein, J.P.8
Kolb, H.J.9
McGlave, P.B.10
Passweg, J.R.11
Rowlings, P.A.12
Sobocinski, K.A.13
Horowitz, M.M.14
-
7
-
-
13044294682
-
Review: An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: Developed for the Hematology
-
(1999)
Blood
, vol.94
, pp. 1517-1536
-
-
Silver, R.T.1
Woolf, S.H.2
Hehlmann, R.3
Appelbaum, F.A.4
Anderson, J.5
Bennett, C.6
Goldman, J.M.7
Guilhot, F.8
Kantarjian, H.M.9
Lichtin, A.E.10
Talpaz, M.11
Tura, S.12
-
8
-
-
0033485291
-
Interferon α before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure
-
for the German CML-Study Group and the SAKK.
-
(1999)
Blood
, vol.94
, pp. 3668-3677
-
-
Hehlmann, R.1
Hochhaus, A.2
Kolb, H.J.3
Hasford, J.4
Gratwohl, A.5
Heimpel, H.6
Siegert, W.7
Finke, J.8
Ehninger, G.9
Holler, E.10
Berger, U.11
Pfirrmann, M.12
Muth, A.13
Zander, A.14
Fauser, A.A.15
Heyll, A.16
Nerl, C.17
Hossfeld, D.K.18
Loffler, H.19
Pralle20
Tobler, A.21
more..
-
9
-
-
0342541022
-
Long-term follow-up of the Italian trial of interferon-α versus conventional chemotherapy in chronic myeloid leukemia
-
ICSG on CML.
-
(1998)
Blood
, vol.92
, pp. 1541-1548
-
-
-
11
-
-
0027504040
-
Choice of pre-transplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase
-
(1993)
Blood
, vol.82
, pp. 2235-2238
-
-
Goldman, J.M.1
Szydlo, R.2
Horowitz, M.M.3
Gale, R.P.4
Ash, R.C.5
Atkinson, K.6
Dicke, K.A.7
Gluckman, E.8
Herzig, R.H.9
Marmont, A.10
-
14
-
-
0027221458
-
Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia
-
(1993)
J Clin Oncol
, vol.11
, pp. 1055-1061
-
-
Giralt, S.A.1
Kantarjian, H.M.2
Talpaz, M.3
Rios, M.B.4
Del Giglio, A.5
Andersson, B.S.6
Przepiorka, D.7
Deisseroth, A.B.8
Champlin, R.E.9
-
15
-
-
12944310971
-
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: An analysis from the international bone marrow transplant registry
-
(2000)
Blood
, vol.95
, pp. 410-415
-
-
Giralt, S.1
Szydlo, R.2
Goldman, J.M.3
Veum-Stone, J.4
Biggs, J.C.5
Herzig, R.H.6
Klein, J.P.7
McGlave, P.B.8
Schiller, G.9
Gale, R.P.10
Rowlings, P.A.11
Horowitz, M.M.12
-
16
-
-
0031969517
-
Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia
-
(1998)
Haematologica
, vol.83
, pp. 231-236
-
-
Zuffa, E.1
Bandini, G.2
Bonini, A.3
Santucci, M.A.4
Martinelli, G.5
Rosti, G.6
Testoni, N.7
Zaccaria, A.8
Tura, S.9
-
17
-
-
0003197855
-
Survival after allogeneic bone marrow transplantation (BMT) in patients randomised into a trial of IFN-α versus chemotherapy: No significant adverse effect of prolonged IFN-α administration
-
(1995)
Blood
, vol.86
, Issue.SUPPL. 1
-
-
Shepherd, P.1
Richards, S.2
Allan, N.3
-
18
-
-
2642680046
-
Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia
-
(1998)
Bone Marrow Transplant
, vol.22
, pp. 47
-
-
Tomas, J.T.1
Lopez-Lorenzo, J.L.2
Requena, M.J.3
Aguilar, R.4
Steegmann, J.L.5
Camara, R.6
Alegre, A.7
Arranz, R.8
Figuera, A.9
Fernandez-Ranada, J.M.10
-
20
-
-
2642643774
-
Association between pre-transplant interferon-α and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase
-
(1998)
Blood
, vol.92
, pp. 394-401
-
-
Morton, A.J.1
Gooley, T.2
Hansen, J.A.3
Appelbaum, F.R.4
Bruemmer, B.5
Bjerke, J.W.6
Clift, R.7
Martin, P.J.8
Petersdorf, E.W.9
Sanders, J.E.10
Storb, R.11
Sullivan, K.M.12
Woolfrey, A.13
Anasetti, C.14
-
21
-
-
0032480589
-
Risk assessment for patients with chronic myeloid leukemia before allogeneic blood or marrow transplantation
-
For the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
-
(1998)
Lancet
, vol.352
, pp. 1087-1092
-
-
Gratwohl, A.1
Hermans, J.2
Goldman, J.M.3
Frassoni, F.4
Devergie, A.5
Carreras, E.6
Kolb, H.J.7
Gahrton, G.8
Arcese, W.9
Vernant, J.P.10
Ruutu, T.11
de Witte, T.12
van Rhee, F.13
Apperley, J.14
|